ReproCell Inc
F:6RC

Watchlist Manager
ReproCell Inc Logo
ReproCell Inc
F:6RC
Watchlist
Price: 0.605 EUR 1.68%
Market Cap: 56.5m EUR

Operating Margin
ReproCell Inc

-20.1%
Current
-15%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-20.1%
=
Operating Profit
-527.9m
/
Revenue
2.6B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
JP
ReproCell Inc
TSE:4978
13.9B JPY
-20%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
400.9B USD
33%
US
Amgen Inc
NASDAQ:AMGN
176.1B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
154.4B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.9B USD
28%
AU
CSL Ltd
ASX:CSL
85.6B AUD
26%
NL
argenx SE
XBRU:ARGX
44.8B EUR
22%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD
8%
No Stocks Found

ReproCell Inc
Glance View

Market Cap
57.3m EUR
Industry
Biotechnology

ReproCELL Inc. engages in stem cell research. The company is headquartered in Yokohama, Kanagawa-Ken and currently employs 106 full-time employees. The company went IPO on 2013-06-26. The firm operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clinical testing services that is required by hematopoietic stem cell transplantation and organ transplantation.

6RC Intrinsic Value
0.436 EUR
Overvaluation 28%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-20.1%
=
Operating Profit
-527.9m
/
Revenue
2.6B
What is the Operating Margin of ReproCell Inc?

Based on ReproCell Inc's most recent financial statements, the company has Operating Margin of -20.1%.

Back to Top